You are required to be logged in to access the full website
Click here if you have forgotten your username or password
16 November 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), announced on Monday that it has received US Food and Drug Administration (FDA) approval for Gazyva (obinutuzumab) to treat adults with prim...
16 November 2026 - Specialist HIV company ViiV Healthcare, majority owned by GSK (LON:GSK), with Shionogi as a shareholder, said on Monday that it has received a positive recommendation from the European Medicines Agency's Committee for Medicina...
16 November 2026 - UK biotechnology company TRIMTECH Therapeutics announced on Monday that it has entered into a strategic research collaboration, option and licence agreement with Biogen International GmbH, part of US biotechnology company Biogen In...
16 November 2026 - Biopharmaceutical company Aelis Farma (Euronext: AELIS) announced on Monday that it has received a second positive recommendation from the Independent Data Monitoring Committee (IDMC) following its review of the Phase 2b trial of A...
16 November 2026 - CARsgen Therapeutics Holdings Limited (HK:2171), a Chinese developer of innovative CAR T-cell therapies, announced on Saturday that satricabtagene autoleucel (satri-cel, product code: CT041), an autologous CAR T-cell therapy produc...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe